VasoGenix Pharmaceuticals Presents at Medtech Insight's ``Investment In Innovation (In3) BOSTON: A Preview of Early-Stage Medical Technology Companies'' Conference.BOSTON -- VasoGenix Pharmaceuticals, Inc. has announced that it will be presenting at 9:30 AM, October 11, 2005, at Medtech Insight's "Investment In Innovation (In3) BOSTON: A Preview of Early-Stage Medical Technology Companies" Conference, taking place October 10-11, 2005, at The Westin Copley Place Hotel in Boston. The presentation will focus on the funding and product development status of the company. VasoGenix is a pharmaceutical company focused on the development of a pipeline of cardiology products based on its proprietary position with Calcitonin calcitonin /cal·ci·to·nin/ (-to´nin) a polypeptide hormone secreted by C cells of the thyroid gland, and sometimes of the thymus and parathyroids, which lowers calcium and phosphate concentration in plasma and inhibits bone resorption. Gene Related Peptide (CGRP CGRP Calcitonin Gene-Related Peptide CGRP Controlled Goods Registration Program CGRP Coolant Group (TARTAR) CGRP Common Hardware Reference Platform ). Among these potential products are the treatment of myocardial infarction myocardial infarction: see under infarction. (MI) and congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. (CHF CHF In currencies, this is the abbreviation for the Swiss Franc. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. ). MI is America's #1 killer for both men and women. CHF is one of America's most morbid diseases for people over 65 and is America's #1 medical expense, estimated at $38 billion. For more information on VasoGenix Pharmaceuticals, Inc. and to learn more about CGRP, visit the company web site at www.vasogenix.net. Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. To register for the "Investment In Innovation Boston" conference or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512, e-mail kristy@medtechinsight.com, or visit www.medtechinsight.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion